KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Deffered Revenue: 2009-2012

Historic Non-Current Deffered Revenue for Bausch Health Companies (BHC) over the last 4 years, with Dec 2012 value amounting to $36.1 million.

  • Bausch Health Companies' Non-Current Deffered Revenue fell 5.31% to $36.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $36.1 million, marking a year-over-year decrease of 5.31%. This contributed to the annual value of $36.1 million for FY2012, which is 5.31% down from last year.
  • According to the latest figures from Q4 2012, Bausch Health Companies' Non-Current Deffered Revenue is $36.1 million, which was down 1.63% from $36.7 million recorded in Q3 2012.
  • In the past 5 years, Bausch Health Companies' Non-Current Deffered Revenue ranged from a high of $78.0 million in Q2 2009 and a low of -$7.8 million during Q1 2009.
  • For the 3-year period, Bausch Health Companies' Non-Current Deffered Revenue averaged around $45.1 million, with its median value being $42.0 million (2011).
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 922.10% in 2010, then crashed by 30.03% in 2011.
  • Over the past 4 years, Bausch Health Companies' Non-Current Deffered Revenue (Quarterly) stood at $69.2 million in 2009, then decreased by 27.76% to $50.0 million in 2010, then declined by 23.73% to $38.2 million in 2011, then dropped by 5.31% to $36.1 million in 2012.
  • Its last three reported values are $36.1 million in Q4 2012, $36.7 million for Q3 2012, and $37.9 million during Q2 2012.